(SUPN) Supernus - Performance 18.7% in 12m
SUPN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
27.57%
#35 in Peer-Group
Rel. Strength
65.57%
#2554 in Stock-Universe
Total Return 12m
18.72%
#47 in Peer-Group
Total Return 5y
33.50%
#39 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 29.2 |
| P/E Forward | 20.2 |
| High / Low | USD |
|---|---|
| 52 Week High | 40.00 USD |
| 52 Week Low | 25.77 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 25.09 |
| Buy/Sell Signal +-5 | 0.60 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SUPN (18.7%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: SUPN vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for SUPN
| Total Return (including Dividends) | SUPN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.22% | 2.04% | 4.55% |
| 3 Months | -3.76% | -7.24% | 10.78% |
| 12 Months | 18.72% | -5.41% | 14.71% |
| 5 Years | 33.50% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | SUPN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -47.9% | 34.5% | 79.2% |
| 3 Months | 16.6% | -46.5% | 92.9% |
| 12 Months | 9.1% | -71.8% | 44.2% |
| 5 Years | 50.2% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th43.81 | -3.20% | -5.52% |
| 3 Month | %th39.18 | 3.76% | -13.12% |
| 12 Month | %th76.29 | 25.52% | 3.50% |
| 5 Years | %th77.84 | -7.02% | -37.18% |
FAQs
Does Supernus (SUPN) outperform the market?
Yes,
over the last 12 months SUPN made 18.72%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months SUPN made -3.76%, while XLV made -7.24%.
Performance Comparison SUPN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SUPN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.4% | -5.8% | -18.9% | 4% |
| US NASDAQ 100 | QQQ | -5.2% | -6.8% | -21% | 4% |
| German DAX 40 | DAX | -4.3% | -1.2% | -31.8% | -11% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.1% | -5.4% | -16.9% | 1% |
| Hongkong Hang Seng | HSI | -4% | -7% | -34.6% | -17% |
| India NIFTY 50 | INDA | -4% | -3.3% | -18.6% | 19% |
| Brasil Bovespa | EWZ | -5.8% | -9% | -43.4% | 5% |
SUPN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.9% | -8% | -25.5% | -10% |
| Consumer Discretionary | XLY | -2.8% | -2.9% | -10.2% | -1% |
| Consumer Staples | XLP | -0.9% | 0.4% | -17.1% | 10% |
| Energy | XLE | -0.1% | -4.7% | -13.4% | 23% |
| Financial | XLF | -4.5% | -4.3% | -22% | -10% |
| Health Care | XLV | -3.5% | -3.3% | -11.7% | 24% |
| Industrial | XLI | -4% | -5% | -25.5% | -5% |
| Materials | XLB | -2.5% | -2.8% | -18.2% | 16% |
| Real Estate | XLRE | 0.1% | -1.2% | -16.3% | 6% |
| Technology | XLK | -5.7% | -10.1% | -22.1% | 7% |
| Utilities | XLU | -2% | -1.3% | -22.2% | -6% |
| Aerospace & Defense | XAR | -6.4% | -11.1% | -40.3% | -34% |
| Biotech | XBI | -2.3% | -3.3% | -4.9% | 30% |
| Homebuilder | XHB | -2.7% | -7.3% | -7.6% | 18% |
| Retail | XRT | -1.3% | -2.6% | -10.2% | 13% |
SUPN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.9% | -6.34% | -9.60% | 29% |
| Natural Gas | UNG | 7.8% | 8.2% | -3.7% | 27% |
| Gold | GLD | 0.5% | 1% | -38.7% | -23% |
| Silver | SLV | -1% | -5.1% | -37.4% | -3% |
| Copper | CPER | -4.7% | -5.4% | -38.6% | 4% |
SUPN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -3.2% | -4.9% | -15.7% | 17% |
| iShares High Yield Corp. Bond | HYG | -2.4% | -3.1% | -17.9% | 8% |